A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) (Estriol in MS)

This study has been completed.

Sponsor:

Collaborators:

Washington University School of Medicine

University of Texas Southwestern Medical Center

Ohio State University

University of Medicine and Dentistry of New Jersey

University of Chicago

Western Institute for Biomedical Research, Salt Lake City, UT

Johns Hopkins University

University of Kansas

University of Minnesota - Clinical and Translational Science Institute

Mayo Clinic

University of Colorado, Aurora

University of New Mexico

University of Pennsylvania

Dartmouth Medical School, Lebanon, NH

National Multiple Sclerosis Society

Synthetic Biologics, Ann Arnor, MI

Information provided by (Responsible Party):

Rhonda Voskuhl, University of California, Los Angeles

ClinicalTrials.gov Identifier:

NCT00451204

First received: March 22, 2007

Last updated: December 18, 2014

Last verified: December 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2014
Primary Completion Date:	July 2014 (Final data collection date for primary outcome measure)